Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
A panel of 5 biomarkers performed well at detecting early-stage pancreatic cancer in individuals with stage I and II pancreatic tumors and in cancer-free individuals at high risk of developing the disease.
